We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
GSK to buy cancer drugmaker Tesaro for $5.1bn
Health Health Headlines News
Britain’s largest drugmaker is paying $75 a share for the business, a 110% premium to the 30-day average price